AIM
PCVX icon

AXA Investment Managers’s Vaxcyte PCVX Stock Holding History

AXA Investment Managers’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$528K Buy
+14,645
New +$485K ﹤0.01% 983

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

AXA Investment Managers's PCVX Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Vaxcyte (PCVX) in Q3 2025: 14,645 shares worth $528K. The stake represents ﹤0.01% of the portfolio and ranks #983 among its holdings.

285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

  • AXA Investment Managers held 14,645 shares of Vaxcyte worth $528K as of Q3 2025.
  • Vaxcyte was a new AXA Investment Managers position in Q3 2025.
  • Vaxcyte made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #983 holding.
  • 285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.